Literature DB >> 21806320

DNase1: a new personalized therapy for cancer?

Karli Rosner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21806320     DOI： 10.1586/era.11.90

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  5 in total

Review 1.  Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies.

Authors:  Medina Mamtimin; Akif Pinarci; Chao Han; Attila Braun; Hans-Joachim Anders; Thomas Gudermann; Elmina Mammadova-Bach
Journal:  Front Oncol       Date:  2022-04-27       Impact factor: 5.738

2.  Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment.

Authors:  Ludmila A Alekseeva; Nadezhda L Mironova; Evgenyi V Brenner; Alexander M Kurilshikov; Olga A Patutina; Marina A Zenkova
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

3.  Deoxyribonuclease 1-like 3 Inhibits Hepatocellular Carcinoma Progression by Inducing Apoptosis and Reprogramming Glucose Metabolism.

Authors:  Yusha Xiao; Kang Yang; Pengpeng Liu; Dong Ma; Ping Lei; Quanyan Liu
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 4.  Role of Cell-Free DNA and Deoxyribonucleases in Tumor Progression.

Authors:  Ludmila Alekseeva; Nadezhda Mironova
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

Review 5.  Nuclease-like metalloscissors: Biomimetic candidates for cancer and bacterial and viral infections therapy.

Authors:  Marzieh Anjomshoa; Bagher Amirheidari
Journal:  Coord Chem Rev       Date:  2022-02-05       Impact factor: 22.315
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.